MA40990A - Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle - Google Patents

Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle

Info

Publication number
MA40990A
MA40990A MA040990A MA40990A MA40990A MA 40990 A MA40990 A MA 40990A MA 040990 A MA040990 A MA 040990A MA 40990 A MA40990 A MA 40990A MA 40990 A MA40990 A MA 40990A
Authority
MA
Morocco
Prior art keywords
dimethyl fumarate
formulations including
matrix formulations
including dimethyl
pharmaceutical matrix
Prior art date
Application number
MA040990A
Other languages
English (en)
Inventor
Shyam B Karki
Cheuk-Yui Leung
Yiqing Lin
Peter Zawaneh
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA40990A publication Critical patent/MA40990A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA040990A 2014-11-19 2015-11-18 Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle MA40990A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19

Publications (1)

Publication Number Publication Date
MA40990A true MA40990A (fr) 2017-09-26

Family

ID=54838418

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040990A MA40990A (fr) 2014-11-19 2015-11-18 Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle

Country Status (13)

Country Link
US (2) US20190083404A1 (fr)
EP (1) EP3220897A1 (fr)
JP (2) JP6901393B2 (fr)
KR (1) KR20170086053A (fr)
CN (2) CN107205942A (fr)
AU (2) AU2015349891B2 (fr)
CA (1) CA2967645A1 (fr)
EA (1) EA201791089A1 (fr)
HK (1) HK1244215A1 (fr)
IL (1) IL252105A0 (fr)
MA (1) MA40990A (fr)
MX (1) MX2017006561A (fr)
WO (1) WO2016081671A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016273068A1 (en) 2015-06-01 2017-12-21 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
WO2023036702A1 (fr) 2021-09-09 2023-03-16 It Pharmagus Limited Procédé destiné à la fabrication d'un corps solide sous forme galénique orale d'un produit pharmaceutique ou d'un complément alimentaire

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0013825A (pt) * 1999-08-31 2002-07-23 Gruenenthal Chemie Formas de apresentação de tramadol
EP1886665A1 (fr) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Système thérapeutique gastro-retentif
EP3295936A1 (fr) * 2009-01-09 2018-03-21 Forward Pharma A/S Formulation pharmaceutique comprenant un ou plusieurs esters d'acide fumarique dans une matrice d'érosion
EP2424357A4 (fr) * 2009-04-29 2012-10-10 Biogen Idec Inc Traitement de la neurodégénérescence et de la neuroinflammation
AU2012222074A1 (en) * 2011-02-25 2013-09-12 National Institutes Of Health Chalcone derivatives as Nrf2 activators
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
US20130216615A1 (en) * 2012-02-07 2013-08-22 David Goldman Pharmaceutical Compositions Containing Dimethyl Fumarate
WO2014031897A1 (fr) * 2012-08-22 2014-02-27 Xenoport, Inc. Formes pharmaceutiques orales possédant une charge élevée de (n,n-diéthylcarbamoyl)méthyl méthyl(2e)but-2-ène-l,4-dioate
ES2733961T3 (es) * 2012-12-21 2019-12-03 Biogen Ma Inc Derivados de fumarato sustituidos con deuterio
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Also Published As

Publication number Publication date
EA201791089A1 (ru) 2017-11-30
EP3220897A1 (fr) 2017-09-27
CA2967645A1 (fr) 2016-05-26
AU2015349891A1 (en) 2017-05-25
JP2021152046A (ja) 2021-09-30
HK1244215A1 (zh) 2018-08-03
AU2015349891B2 (en) 2021-04-01
WO2016081671A1 (fr) 2016-05-26
CN107205942A (zh) 2017-09-26
US20190175510A1 (en) 2019-06-13
AU2021204247A1 (en) 2021-07-22
CN113262205A (zh) 2021-08-17
KR20170086053A (ko) 2017-07-25
US20190083404A1 (en) 2019-03-21
WO2016081671A8 (fr) 2016-07-21
JP2017534667A (ja) 2017-11-24
IL252105A0 (en) 2017-07-31
MX2017006561A (es) 2018-02-21
JP6901393B2 (ja) 2021-07-14

Similar Documents

Publication Publication Date Title
IL246978A0 (en) New paracetamol formulations
BR112018009951A2 (pt) fármaco oftálmico
DK3722274T3 (da) 2-perfluorbutylpentan til oftalmisk indgivelse
MA42844A (fr) Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3171921T3 (da) Lægemiddelafgivelsesindretning
MA50541A (fr) Formulations pharmaceutiques
MA42303A (fr) Formulations pharmaceutiques
DK3634377T3 (da) Farmaceutisk formulering
MA46867A (fr) Formulations pharmaceutiques
DK3348260T3 (da) Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse
DK3199161T3 (da) Farmaceutisk præparat
MA40982A (fr) Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
MA43705A (fr) Formulation pharmaceutique
DE102015120393A8 (de) Lendenstützvorrichtung
MA47516A (fr) Composition pharmaceutique
MA49822A (fr) Combinaison pharmaceutique comprenant du ponesimod
MA44079A (fr) Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine
DK2992967T3 (da) Medikamentdispenser
DK3280447T3 (da) Farmaceutiske formuleringer
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
MA45126A (fr) Formulation pharmaceutique antifongique
EP3383371C0 (fr) Formulation pharmaceutique
MA40990A (fr) Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle
DK3215118T3 (da) Lægemiddelanordningsenhed indeholdende quinagolid